Phosphagenics CEO steps down

Monday, 22 July, 2013

Dr Esra Ogru, CEO of Phosphagenics (ASX: POH), handed in her resignation as a director of the company effective as of last Thursday 18 July 2013.

The Phosphagenics board suspended Esra Ogru on 1 July, after it discovered apparent irregular transactions in the company’s invoicing and accounting records.

The company expects to announce the key findings of an independent investigation on Wednesday 24 July 2013.

Phosphagenics’ shares were trading at $0.105 at about 3 pm on Monday.

AusBiotech and Proto Axiom have announced a partnership to strengthen national coordination...

The success of a cervical cancer elimination program has led to the signing of a memorandum of...

Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology...

Content from other channels on our network

How Floor Scrubbers Support Infection Prevention In Healthcare

The AI Revolution in Clinical Trials: New Research Reveals Why Industry Leaders Are Making the Shift Now

Hospital’s "recovery at work" collaborative approach proves a winning model

Medicine shortages are testing Australia's health system and clinicians need national support

A Day in the Life of a home support clinical care team manager

Save Food Initiative strengthens global alliance with UNIDO and WPO

Nutrient content claims on alcohol, Australian research

Fast detection of beverage spoilage using the SureTect Multiplex PCR Assay

ABARES predicts Australia's produce will exceed $100bn in 2026–27

HVAC&R behind the scenes of food: the systems, skills and standards shaping the next decade

Australia Post sets 2030 emissions targets

UNSW tracks groundwater recharging: study

$320m to power Western Sydney International Airport

Water-repellent membrane advances desalination

Aussie-made remote telemetry unit tech expands into NZ